• Virendra Shiva
• Yogita Tyagi
• Hiba Parveen
• Praveen Kumar Ashok

The advantage of transdermal medication delivery is that it is comparatively painless. The benefits of using the skin as a portal for medication entry include the ease of access, the skin's enormous surface area, systemic access via underlying circulatory and lymphatic networks, and the non-invasiveness of drug administration. Transdermal delivery, often known as medication distribution through the skin for systemic effects, was invented in 1981 when Ciba-Geigy released Transderm V (now sold as Transderm Scop) to treat motion sickness and stop nausea and vomiting. Transdermal medication delivery allows for consistent blood level profiles, regulated drug release into the patient, fewer systemic side effects, and occasionally higher efficacy than other dose forms.

Transdermal Patch, Polymer, Non-toxic, Controlled Release

"“TRANSDERMAL PATCHES” A systematic review on Transdermal Patches", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 8, page no.h27-h34, August-2023, Available :http://www.jetir.org/papers/JETIR2308704.pdf

"“TRANSDERMAL PATCHES” A systematic review on Transdermal Patches", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 8, page no. pph27-h34, August-2023, Available at : http://www.jetir.org/papers/JETIR2308704.pdf